Literature DB >> 1370872

Immunocytochemical localization of vasoactive intestinal peptide and substance P in the colon from normal subjects and patients with inflammatory bowel disease.

S Mazumdar1, K M Das.   

Abstract

Neuropeptides form a part of the brain-gut axis which may regulate gastrointestinal functions, including immune regulation. Various changes in the neuropeptides--most important, vasoactive intestinal peptide and substances P (VIP and SP)--have been described in inflammatory bowel disease. We employed a sensitive immunoperoxidase (avidin-biotin-peroxidase complex) technique, using anti-VIP and anti-SP antibodies to localize and compare the distribution of VIP and SP in the colon. Colon specimens from 19 normal subjects, eight patients with ulcerative colitis (UC), and eight with Crohn's disease (CD) were used. In the normal colon, VIP and SP immunoreactivity (IR) were localized in the muscularis mucosa, circular muscles, walls of blood vessels, nerve fibers, and some distinct cells, probably enterochromaffin cells. SP-IR was also present in the epithelial cells, mainly along the basolateral domain. VIP-IR was considerably diminished at all locations in patients with UC and CD. However, the SP-IR was increased in UC in the colonic epithelial cells along the basolateral areas. The SP-IR was intense in patients with CD, in the epithelium, the granulomas, cells lining the mucosal fissure, and in the muscle layers. In contrast to normals, SP-IR in patients with CD was observed both in the longitudinal and circular muscles. We conclude that VIP-IR and SP-IR are distributed widely in the mucosa, submucosa, and in the circular muscle in normal colon. VIP-IR is decreased in UC and CD, whereas SP-IR is increased in both, but more so in CD.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1370872

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  24 in total

1.  Abnormal neuropeptide concentration in rectal mucosa of patients with inflammatory bowel disease.

Authors:  H Yamamoto; K Morise; K Kusugami; A Furusawa; T Konagaya; Y Nishio; H Kaneko; K Uchida; H Nagai; T Mitsuma; H Nagura
Journal:  J Gastroenterol       Date:  1996-08       Impact factor: 7.527

Review 2.  Tachykinin peptide, substance P, and its receptor NK-1R play an important role in alimentary tract mucosal inflammation during cytotoxic therapy.

Authors:  P S Satheeshkumar; Minu P Mohan
Journal:  Dig Dis Sci       Date:  2014-07-01       Impact factor: 3.199

Review 3.  Challenges in understanding the immunopathogenesis of Cryptosporidium infections in humans.

Authors:  R J Kothavade
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-12       Impact factor: 3.267

4.  Neuropeptides and nerve growth in inflammatory bowel diseases: a quantitative immunohistochemical study.

Authors:  C M Y Lee; R K Kumar; D Z Lubowski; E Burcher
Journal:  Dig Dis Sci       Date:  2002-03       Impact factor: 3.199

Review 5.  Human immune responses in cryptosporidiosis.

Authors:  Anoli Borad; Honorine Ward
Journal:  Future Microbiol       Date:  2010-03       Impact factor: 3.165

6.  Substance P- and vasoactive intestinal polypeptide-immunoreactive innervation in normal and inflamed pouches after restorative proctocolectomy for ulcerative colitis.

Authors:  U Keränen; H Järvinen; T Kiviluoto; E Kivilaakso; S Soinila
Journal:  Dig Dis Sci       Date:  1996-08       Impact factor: 3.199

7.  Substance P--an underlying factor for pouchitis? Prospective study of substance P- and vasoactive intestinal polypeptide-immunoreactive innervation and mast cells.

Authors:  U Keränen; H Järvinen; P Kärkkäinen; T Kiviluoto; E Kivilaakso; S Soinila
Journal:  Dig Dis Sci       Date:  1996-08       Impact factor: 3.199

8.  Neuroendocrine changes in colon of mice with a disrupted IL-2 gene.

Authors:  B F Qian; M El-Salhy; S Melgar; M L Hammarström; A Danielsson
Journal:  Clin Exp Immunol       Date:  2000-06       Impact factor: 4.330

9.  Colonic delivery of vasoactive intestinal peptide nanomedicine alleviates colitis and shows promise as an oral capsule.

Authors:  Shubha Priyamvada; Anoop Kumar; Seema Saksena; Hayat Onyuksel
Journal:  Nanomedicine (Lond)       Date:  2020-09-25       Impact factor: 5.307

10.  Substance P induces intestinal wound healing via fibroblasts--evidence for a TGF-beta-dependent effect.

Authors:  Peter Felderbauer; Kerem Bulut; Karoline Hoeck; Susanne Deters; Wolfgang E Schmidt; Peter Hoffmann
Journal:  Int J Colorectal Dis       Date:  2007-05-23       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.